埃库利祖马布的快速反应:一种救援疗法,用于呼吸机依赖的耐火性肌痛危机
Yohei Takenobu1,2, Kazutoshi Ikeda1,2, Sachiko Hasebe1,2
1Department of Neurology, Osaka Red Cross Hospital, Osaka, Japan.
Immunological medicine
|May 6, 2025
概括
埃奎利祖马布为经历肌危机 (MC) 的患者提供了一个有前途的救援疗法,这种患者对标准治疗不耐药. 这种方法导致了严重的肌痛性硬化症 (MG) 病例的显著恢复和呼吸机独立.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 临界护理医学 临界护理医学
背景情况:
- 肌痛性危机 (MC) 是肌痛性严重并发症 (MG) 的严重,危及生命的并发症.
- 一些MC患者对常规免疫疗法,如IVIg和血交换,表现出耐药性.
- 耐火性MC需要探索替代治疗策略.
研究的目的:
- 报告一例耐火性肌危机的病例,该病例已成功用eculizumab治疗.
- 审查关于在耐火性MC中使用eculizumab的现有文献.
- 强调eculizumab作为严重的,耐治疗的MC的潜在救援疗法.
主要方法:
- 一个患者的病例报告MC耐固醇和IVIg,需要机械通风.
- 用于管理eculizumab.
- 在耐火MC中发表的eculizumab病例的文献综述.
主要成果:
- 患者在开始使用eculizumab后2天内迅速改善,使得可以停止呼吸器治疗.
- 随后的eculizumab剂量导致功能恢复和患者独立.
- 文献综述确定了10例具有良好的结果的病例,并指出呼吸道感染是复杂因素.
结论:
- 埃奎利祖马布 (Eculizumab) 证明了作为耐火性肌痛危机的救援疗法的显著有效性.
- 尽管被排除在RCT之外,但eculizumab对于严重的MC是一个可行的选择.
- 需要对包括MC患者在内的更大规模研究进行进一步研究.
相关概念视频
01:29Acute Respiratory Failure-V
97
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
97
01:20Myasthenia Gravis: Overview and Treatment
934
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
934
01:15Myasthenia Gravis: Diagnostic Tests
530
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
530
01:19Depolarizing Blockers: Pharmocokinetics
286
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
286
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
151
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
151
01:28Depolarizing Blockers: Mechanism of Action
1.1K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.1K